Advanced search
Publication Cover
Acta Cardiologica Volume 78, 2023 - Issue 7
Submit an article Journal homepage
99
Views
3
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Evaluation the value of H2FPEF score and HFA-PEFF step E score in the diagnosis of heart failure with preserved ejection fraction

Zhuolin Wanga Department of Geriatrics, Fujian Key Laboratory of Vascular Aging (Fujian Medical University), Fujian Institute of Geriatrics, Fuzhou, Fujian, China;b Department of Cardiology, Fujian Heart Disease Center, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
,
Jun Fanga Department of Geriatrics, Fujian Key Laboratory of Vascular Aging (Fujian Medical University), Fujian Institute of Geriatrics, Fuzhou, Fujian, China;b Department of Cardiology, Fujian Heart Disease Center, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
&
Huashan Honga Department of Geriatrics, Fujian Key Laboratory of Vascular Aging (Fujian Medical University), Fujian Institute of Geriatrics, Fuzhou, Fujian, China;b Department of Cardiology, Fujian Heart Disease Center, Fujian Medical University Union Hospital, Fuzhou, Fujian, ChinaCorrespondence[email protected]
Pages 790-795 | Received 22 Mar 2022, Accepted 30 May 2023, Published online: 15 Jun 2023

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Patrizio Lancellotti. (2023) A journey in structural heart failure. Acta Cardiologica 78:10, pages 1065-1067.
Read now
Patrizio Lancellotti. (2023) Special issue on diagnosis and management of heart failure. Acta Cardiologica 78:7, pages 749-753.
Read now
Bülent Özlek & Eda Özlek. (2023) How useful are the H2FPEF and HFA-PEFF scoring algorithms in the diagnosis of heart failure with preserved ejection fraction?. Acta Cardiologica 0:0, pages 1-2.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.